Impact of mouse contamination in genomic profiling of patient-derived models and best practice for robust analysis

Patient-derived xenograft and cell line models are popular models for clinical cancer research. However, the inevitable inclusion of a mouse genome in a patient-derived model is a remaining concern in the analysis.